Skip to main content

and
  1. Article

    Open Access

    T cell assays differentiate clinical and subclinical SARS-CoV-2 infections from cross-reactive antiviral responses

    Identification of protective T cell responses against SARS-CoV-2 requires distinguishing people infected with SARS-CoV-2 from those with cross-reactive immunity to other coronaviruses. Here we show a range of ...

    Ane Ogbe, Barbara Kronsteiner, Donal T. Skelly, Matthew Pace in Nature Communications (2021)

  2. Article

    Open Access

    How can we improve priority-setting for investments in health research? A case study of tuberculosis

    Although enhanced priority-setting for investments in health research for development is essential to tackling inequalities in global health, there is a lack of consensus on an optimal priority-setting process...

    Mishal S. Khan, Afifah Rahman-Shepherd in Health Research Policy and Systems (2019)

  3. Article

    Open Access

    Differences in monocyte: lymphocyte ratio and Tuberculosis disease progression in genetically distinct populations of macaques

    Monocyte:lymphocyte ratio (M:L) has been identified as a risk factor in development of TB disease in children and those undergoing treatment for HIV in co-infected individuals. Retrospective analysis was perfo...

    Laura Sibley, Karen Gooch, Alice Wareham, Susan Gray in Scientific Reports (2019)

  4. Article

    Open Access

    Investments in tuberculosis research – what are the gaps?

    Through decades of research, numerous studies have generated robust evidence about effective interventions for tuberculosis control. Yet, the global annual decline in incidence of approximately 1 % is evidence...

    Mishal S. Khan, Helen Fletcher, Richard Coker in BMC Medicine (2016)

  5. Article

    Open Access

    A new tool for tuberculosis vaccine screening: Ex vivo Mycobacterial Growth Inhibition Assay indicates BCG-mediated protection in a murine model of tuberculosis

    In the absence of a validated animal model and/or an immune correlate which predict vaccine-mediated protection, large-scale clinical trials are currently the only option to prove efficacy of new tuberculosis ...

    Andrea Zelmer, Rachel Tanner, Elena Stylianou, Timon Damelang in BMC Infectious Diseases (2016)

  6. Article

    Open Access

    Uniting to end the TB epidemic: advances in disease control from prevention to better diagnosis and treatment

    Tuberculosis is a major global cause of morbidity and mortality. Despite recent advances in containing the epidemic, several challenges continue to slow progress towards elimination including the continuing im...

    Ibrahim Abubakar, Marc Lipman, Timothy D. McHugh, Helen Fletcher in BMC Medicine (2016)

  7. Article

    Open Access

    The association between the ratio of monocytes:lymphocytes at age 3 months and risk of tuberculosis (TB) in the first two years of life

    Recent transcriptomic studies revived a hypothesis suggested by historical studies in rabbits that the ratio of peripheral blood monocytes to lymphocytes (ML) is associated with risk of tuberculosis (TB) disea...

    Vivek Naranbhai, Soyeon Kim, Helen Fletcher, Mark F Cotton, Avy Violari in BMC Medicine (2014)

  8. Article

    Open Access

    What are the most effective techniques in changing obese individuals’ physical activity self-efficacy and behaviour: a systematic review and meta-analysis

    Increasing self-efficacy is generally considered to be an important mediator of the effects of physical activity interventions. A previous review identified which behaviour change techniques (BCTs) were associ...

    Ellinor K Olander, Helen Fletcher in International Journal of Behavioral Nutrit… (2013)